Riccardo Samaritani
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Journal: International journal of cancer
Published: April 15, 2019
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.
Journal: Cancer biology & therapy
Published: November 08, 2018
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
Journal: Journal of cellular physiology
Published: October 10, 2018
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 14, 2018
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration-resistant prostate cancer treated with 223Radium.
Journal: European journal of cancer care
Published: April 05, 2018
Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study.
Journal: BMC cancer
Published: February 25, 2014
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer.
Journal: Journal of cancer research and clinical oncology
Published: February 06, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026